Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents
Menzies et al report three cases of severe and persistent hypoglycemia due to gatifloxacin in adults with diabetes mellitus who were taking oral hypoglycemic agents. This phenomenon, which is not a quinolone class effect, has important clinical implications for diabetic patients who are also treated...
Gespeichert in:
| Veröffentlicht in: | The American journal of medicine 2002-08, Vol.113 (3), p.232-234 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 234 |
|---|---|
| container_issue | 3 |
| container_start_page | 232 |
| container_title | The American journal of medicine |
| container_volume | 113 |
| creator | MENZIES, Dhananjai J DORSAINVIL, Pierre A CUNHA, Burke A JOHNSON, Diane H |
| description | Menzies et al report three cases of severe and persistent hypoglycemia due to gatifloxacin in adults with diabetes mellitus who were taking oral hypoglycemic agents. This phenomenon, which is not a quinolone class effect, has important clinical implications for diabetic patients who are also treated with gatifloxacin. |
| doi_str_mv | 10.1016/S0002-9343(02)01158-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_232331531</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>181713491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-62948b0837feb759c917bb9deeab6394df93148cd401c15057d45d022949111b3</originalsourceid><addsrcrecordid>eNpNkF1LwzAUhoMobk5_ghIEQS-qOUnTNpcy_IKBF9PrmKbpltG1M8nU_XuzD5xXhwPP-57Dg9A5kFsgkN2NCSE0ESxl14TeEABeJOQA9YFznuSQ0UPU_0N66MT7WVyJ4Nkx6gGlpGAF66OPsfkyzmDVVnhhnLc-mDbg6WrRTZqVNnOrcLU0OHR4ooKtm-5Hadti2wbjlA62a_G3DVPcOdX8j2msJrHJn6KjWjXenO3mAL0_PrwNn5PR69PL8H6UaFbkIcmoSIsyPpXXpsy50ALyshSVMarMmEirWjBIC12lBDRwwvMq5RWhMSYAoGQDdLntXbjuc2l8kLNu6dp4UlJGGQPOIEJ8C2nXee9MLRfOzpVbSSByrVVutMq1MxnnRqskMXexK1-Wc1PtUzuPEbjaAcpr1dROtdr6PceKImUE2C8fr4BP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232331531</pqid></control><display><type>article</type><title>Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>MENZIES, Dhananjai J ; DORSAINVIL, Pierre A ; CUNHA, Burke A ; JOHNSON, Diane H</creator><creatorcontrib>MENZIES, Dhananjai J ; DORSAINVIL, Pierre A ; CUNHA, Burke A ; JOHNSON, Diane H</creatorcontrib><description>Menzies et al report three cases of severe and persistent hypoglycemia due to gatifloxacin in adults with diabetes mellitus who were taking oral hypoglycemic agents. This phenomenon, which is not a quinolone class effect, has important clinical implications for diabetic patients who are also treated with gatifloxacin.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/S0002-9343(02)01158-0</identifier><identifier>PMID: 12208383</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier</publisher><subject>Administration, Oral ; Aged ; Aged, 80 and over ; Anti-Infective Agents - administration & dosage ; Anti-Infective Agents - adverse effects ; Associated diseases and complications ; Bacterial Infections - drug therapy ; Biological and medical sciences ; Blood Glucose - drug effects ; Case studies ; Diabetes ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes. Impaired glucose tolerance ; Drug Interactions ; Drug therapy ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Female ; Fluoroquinolones ; Follow-Up Studies ; Gatifloxacin ; Humans ; Hypoglycemia - diagnosis ; Hypoglycemia - etiology ; Hypoglycemic Agents - administration & dosage ; Hypoglycemic Agents - adverse effects ; Male ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; Risk Assessment ; Side effects</subject><ispartof>The American journal of medicine, 2002-08, Vol.113 (3), p.232-234</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Aug 15, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-62948b0837feb759c917bb9deeab6394df93148cd401c15057d45d022949111b3</citedby><cites>FETCH-LOGICAL-c387t-62948b0837feb759c917bb9deeab6394df93148cd401c15057d45d022949111b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13884301$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12208383$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MENZIES, Dhananjai J</creatorcontrib><creatorcontrib>DORSAINVIL, Pierre A</creatorcontrib><creatorcontrib>CUNHA, Burke A</creatorcontrib><creatorcontrib>JOHNSON, Diane H</creatorcontrib><title>Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Menzies et al report three cases of severe and persistent hypoglycemia due to gatifloxacin in adults with diabetes mellitus who were taking oral hypoglycemic agents. This phenomenon, which is not a quinolone class effect, has important clinical implications for diabetic patients who are also treated with gatifloxacin.</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - administration & dosage</subject><subject>Anti-Infective Agents - adverse effects</subject><subject>Associated diseases and complications</subject><subject>Bacterial Infections - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - drug effects</subject><subject>Case studies</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Drug Interactions</subject><subject>Drug therapy</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Follow-Up Studies</subject><subject>Gatifloxacin</subject><subject>Humans</subject><subject>Hypoglycemia - diagnosis</subject><subject>Hypoglycemia - etiology</subject><subject>Hypoglycemic Agents - administration & dosage</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>Risk Assessment</subject><subject>Side effects</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkF1LwzAUhoMobk5_ghIEQS-qOUnTNpcy_IKBF9PrmKbpltG1M8nU_XuzD5xXhwPP-57Dg9A5kFsgkN2NCSE0ESxl14TeEABeJOQA9YFznuSQ0UPU_0N66MT7WVyJ4Nkx6gGlpGAF66OPsfkyzmDVVnhhnLc-mDbg6WrRTZqVNnOrcLU0OHR4ooKtm-5Hadti2wbjlA62a_G3DVPcOdX8j2msJrHJn6KjWjXenO3mAL0_PrwNn5PR69PL8H6UaFbkIcmoSIsyPpXXpsy50ALyshSVMarMmEirWjBIC12lBDRwwvMq5RWhMSYAoGQDdLntXbjuc2l8kLNu6dp4UlJGGQPOIEJ8C2nXee9MLRfOzpVbSSByrVVutMq1MxnnRqskMXexK1-Wc1PtUzuPEbjaAcpr1dROtdr6PceKImUE2C8fr4BP</recordid><startdate>20020815</startdate><enddate>20020815</enddate><creator>MENZIES, Dhananjai J</creator><creator>DORSAINVIL, Pierre A</creator><creator>CUNHA, Burke A</creator><creator>JOHNSON, Diane H</creator><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>20020815</creationdate><title>Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents</title><author>MENZIES, Dhananjai J ; DORSAINVIL, Pierre A ; CUNHA, Burke A ; JOHNSON, Diane H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-62948b0837feb759c917bb9deeab6394df93148cd401c15057d45d022949111b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - administration & dosage</topic><topic>Anti-Infective Agents - adverse effects</topic><topic>Associated diseases and complications</topic><topic>Bacterial Infections - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - drug effects</topic><topic>Case studies</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Drug Interactions</topic><topic>Drug therapy</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Follow-Up Studies</topic><topic>Gatifloxacin</topic><topic>Humans</topic><topic>Hypoglycemia - diagnosis</topic><topic>Hypoglycemia - etiology</topic><topic>Hypoglycemic Agents - administration & dosage</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>Risk Assessment</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MENZIES, Dhananjai J</creatorcontrib><creatorcontrib>DORSAINVIL, Pierre A</creatorcontrib><creatorcontrib>CUNHA, Burke A</creatorcontrib><creatorcontrib>JOHNSON, Diane H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MENZIES, Dhananjai J</au><au>DORSAINVIL, Pierre A</au><au>CUNHA, Burke A</au><au>JOHNSON, Diane H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2002-08-15</date><risdate>2002</risdate><volume>113</volume><issue>3</issue><spage>232</spage><epage>234</epage><pages>232-234</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Menzies et al report three cases of severe and persistent hypoglycemia due to gatifloxacin in adults with diabetes mellitus who were taking oral hypoglycemic agents. This phenomenon, which is not a quinolone class effect, has important clinical implications for diabetic patients who are also treated with gatifloxacin.</abstract><cop>New York, NY</cop><pub>Elsevier</pub><pmid>12208383</pmid><doi>10.1016/S0002-9343(02)01158-0</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9343 |
| ispartof | The American journal of medicine, 2002-08, Vol.113 (3), p.232-234 |
| issn | 0002-9343 1555-7162 |
| language | eng |
| recordid | cdi_proquest_journals_232331531 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Administration, Oral Aged Aged, 80 and over Anti-Infective Agents - administration & dosage Anti-Infective Agents - adverse effects Associated diseases and complications Bacterial Infections - drug therapy Biological and medical sciences Blood Glucose - drug effects Case studies Diabetes Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Diabetes. Impaired glucose tolerance Drug Interactions Drug therapy Endocrine pancreas. Apud cells (diseases) Endocrinopathies Female Fluoroquinolones Follow-Up Studies Gatifloxacin Humans Hypoglycemia - diagnosis Hypoglycemia - etiology Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Male Medical sciences Miscellaneous Pharmacology. Drug treatments Risk Assessment Side effects |
| title | Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A30%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20and%20persistent%20hypoglycemia%20due%20to%20gatifloxacin%20interaction%20with%20oral%20hypoglycemic%20agents&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=MENZIES,%20Dhananjai%20J&rft.date=2002-08-15&rft.volume=113&rft.issue=3&rft.spage=232&rft.epage=234&rft.pages=232-234&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/S0002-9343(02)01158-0&rft_dat=%3Cproquest_cross%3E181713491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232331531&rft_id=info:pmid/12208383&rfr_iscdi=true |